1991 | OriginalPaper | Buchkapitel
Protein Stabilization
Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.
Wählen Sie Textabschnitte aus um mit Künstlicher Intelligenz passenden Patente zu finden. powered by
Markieren Sie Textabschnitte, um KI-gestützt weitere passende Inhalte zu finden. powered by
For many industrial processes, biocatalysts provide a desirable specificity not possible with either the analogous uncatalyzed chemical reaction or a catalyzed nonenzymatic counterpart. For example, in the conversion of starch to high-fructose corn syrup, α-amylase consistantly yields a product containing 3–5% more dextrose than simple acid hydrolysis, with less impurities and by-products.1 Similarly, rennin (chymosin) is used in the making of cheese because it will specifically cleave only the κ-casein component in milk thus initiating the clotting process.2 The use of biocatalysts however remains limited, because while many applications require harsh conditions (such as temperatures greater than 50 °C) to ensure high productivity, high solubility of substrates, and reduced microbial contamination, these conditions often result in an irreversible inactivation of the enzyme.3 Hence repetitive, time-consuming additions of the costly catalyst are necessary to maintain the process. This dilemma has compelled scientists to search for means to stabilize biocatalysts against irreversible inactivation.